To reiterate that Government will facilitate availability and utilization of safe and adequate quantity of plasma derived products for clinical/ therapeutic use.
To make available adequate resources to develop and organize the plasma/ PDMPs mobilization throughout the country.
To take adequate Regulatory and Legislative steps for monitoring of activities related to plasma derived products.
To encourage Research & Development in the field of blood components, plasma fractionation and plasma derived products.
To strengthen Quality Systems in Blood Transfusion Services for plasma collection, transportation, processing, production and distribution of PDMPs.
